148 related articles for article (PubMed ID: 35289003)
1. Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting.
Mittelheisser V; Coliat P; Moeglin E; Goepp L; Goetz JG; Charbonnière LJ; Pivot X; Detappe A
Adv Mater; 2022 Jun; 34(24):e2110305. PubMed ID: 35289003
[TBL] [Abstract][Full Text] [Related]
2. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes.
Thondawada M; Wadhwani AD; S Palanisamy D; Rathore HS; Gupta RC; Chintamaneni PK; Samanta MK; Dubala A; Varma S; Krishnamurthy PT; Gowthamarajan K
Drug Dev Ind Pharm; 2018 Jul; 44(7):1120-1129. PubMed ID: 29430979
[TBL] [Abstract][Full Text] [Related]
3. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells.
Carney CP; Pandey N; Kapur A; Saadi H; Ong HL; Chen C; Winkles JA; Woodworth GF; Kim AJ
ACS Nano; 2023 Oct; 17(20):19667-19684. PubMed ID: 37812740
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
[TBL] [Abstract][Full Text] [Related]
5. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
[TBL] [Abstract][Full Text] [Related]
6. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
Cirstoiu-Hapca A; Buchegger F; Bossy L; Kosinski M; Gurny R; Delie F
Eur J Pharm Sci; 2009 Oct; 38(3):230-7. PubMed ID: 19632322
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
9. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
10. Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
Montenegro JM; Grazu V; Sukhanova A; Agarwal S; de la Fuente JM; Nabiev I; Greiner A; Parak WJ
Adv Drug Deliv Rev; 2013 May; 65(5):677-88. PubMed ID: 23280372
[TBL] [Abstract][Full Text] [Related]
11. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.
Kamaly N; Xiao Z; Valencia PM; Radovic-Moreno AF; Farokhzad OC
Chem Soc Rev; 2012 Apr; 41(7):2971-3010. PubMed ID: 22388185
[TBL] [Abstract][Full Text] [Related]
12. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
[TBL] [Abstract][Full Text] [Related]
13. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
15. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
16. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
17. Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells.
Escareño N; Hassan N; Kogan MJ; Juárez J; Topete A; Daneri-Navarro A
J Colloid Interface Sci; 2021 Jun; 591():440-450. PubMed ID: 33631531
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.
Valencia PM; Pridgen EM; Rhee M; Langer R; Farokhzad OC; Karnik R
ACS Nano; 2013 Dec; 7(12):10671-80. PubMed ID: 24215426
[TBL] [Abstract][Full Text] [Related]
20. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
Ding B; Zhang W; Wu X; Wang J; Xie C; Huang X; Zhan S; Zheng Y; Huang Y; Xu N; Ding X; Gao S
Oncotarget; 2016 Aug; 7(35):57160-57170. PubMed ID: 27494835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
